Stay updated on Nivolumab vs Cabiralizumab in T Cell Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab vs Cabiralizumab in T Cell Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab vs Cabiralizumab in T Cell Lymphoma Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Revision: v3.5.0 has been added and Revision: v3.4.3 has been removed.
    Difference
    0.1%
    Check dated 2026-03-19T23:45:46.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3. This change does not alter any study data, eligibility criteria, or outcomes.
    Difference
    0.1%
    Check dated 2026-03-12T19:41:57.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    45 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2 on the page.
    Difference
    0.1%
    Check dated 2026-02-12T01:46:39.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1.
    Difference
    0.1%
    Check dated 2026-02-04T23:44:25.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    The page now includes a glossary toggle, capitalization updates to metadata labels (e.g., 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'), and a new revision tag v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T19:41:56.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was added and the previous v3.3.3 revision was removed, representing a minor site maintenance update without changes to study data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T04:01:08.000Z thumbnail image

Stay in the know with updates to Nivolumab vs Cabiralizumab in T Cell Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Cabiralizumab in T Cell Lymphoma Clinical Trial page.